Landscape Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-40,035
| Closed | -$221K | – | 661 |
|
|
2018
Q4 | $221K | Buy |
+40,035
| New | +$221K | 0.02% | 744 |
|
|
2018
Q3 | – | Sell |
-72,879
| Closed | -$727K | – | 691 |
|
|
2018
Q2 | $727K | Sell |
72,879
-43,537
| -37% | -$434K | 0.06% | 234 |
|
|
2018
Q1 | $1.11M | Buy |
116,416
+82,315
| +241% | +$784K | 0.08% | 207 |
|
|
2017
Q4 | $507K | Buy |
34,101
+19,755
| +138% | +$294K | 0.05% | 389 |
|
|
2017
Q3 | $282K | Sell |
14,346
-11,717
| -45% | -$230K | 0.03% | 401 |
|
|
2017
Q2 | $375K | Buy |
26,063
+4,109
| +19% | +$59.1K | 0.04% | 229 |
|
|
2017
Q1 | $202K | Buy |
21,954
+4,454
| +25% | +$41K | 0.02% | 442 |
|
|
2016
Q4 | $182K | Hold |
17,500
| – | – | 0.02% | 486 |
|
|
2016
Q3 | $158K | Sell |
17,500
-104,826
| -86% | -$946K | 0.02% | 395 |
|
|
2016
Q2 | $915K | Sell |
122,326
-2,675
| -2% | -$20K | 0.12% | 195 |
|
|
2016
Q1 | $1.13M | Buy |
125,001
+83,601
| +202% | +$753K | 0.14% | 217 |
|
|
2015
Q4 | $535K | Buy |
+41,400
| New | +$535K | 0.07% | 434 |
|